SMTL ID : 4agw.1 (1 other biounit)

Discovery of a small molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFRalpha, Kit, and Src kinases

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x NG7: 3-{2-[(cyclopropylcarbonyl)amino][1,3]thiazolo[5,4-b]pyridin-5-yl}-N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromet hyl)phenyl}benzamide(Non-covalent)

NG7.1: 26 residues within 4Å: Chain A: L.26, A.46, K.48, E.63, V.66, M.67, L.70, L.75, V.76, T.91, E.92, Y.93, M.94, S.95, K.96, G.97, Y.135, V.136, H.137, R.138, L.146, V.155, A.156, D.157, F.158 Ligands: MES.2 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:A.46, A:K.48, A:K.48, A:E.63, A:V.66, A:L.146, A:F.158 Hydrogen bonds: A:Y.93, A:M.94, A:G.97, A:D.157 Water bridges: A:K.48, A:K.48, A:S.98 Halogen bonds: A:V.155

1 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.2: 5 residues within 4Å: Chain A: M.133, N.134, Y.135, V.136 Ligands: NG7.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.135, A:V.136

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 6 residues within 4Å: Chain A: K.180, V.214, Y.216, P.217, G.218, M.219 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.180, A:K.180, A:G.218, A:M.219

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Weisberg, E. et al., Discovery of a Small-Molecule Type II Inhibitor of Wild-Type and Gatekeeper Mutants of Bcr-Abl, Pdgfralpha, Kit, and Src Kinases: Novel Type II Inhibitor of Gatekeeper Mutants. Blood (2010)

Release Date

2012-02-15

Peptides

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC

Related Entries With Identical Sequence